Spironolactone Versus Placebo or in Combination with Steroids for Hirsutism and Acne

    October 2003
    Julie Brown, Cindy Farquhar, Olivia Lee, Robyn Toomath, Ruth Jepson
    Image of study
    TLDR Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.
    The review aimed to evaluate the effectiveness of spironolactone, alone or in combination with steroids, in treating hirsutism and acne in women. Seven small randomized controlled trials with no more than 41 participants each were included. The review found that 100 mg/day of spironolactone significantly improved hair growth and reduced Ferriman-Gallwey scores when compared to placebo. Additionally, spironolactone was superior to finasteride 5 mg/day and low-dose cyproterone acetate 12.5 mg/day in maintaining these improvements up to 12 months after treatment ended. However, the effectiveness of spironolactone for acne could not be determined due to the small sample sizes of the trials. The wide confidence intervals and small sample populations limit the confidence in these findings, making it difficult to assess the clinical value of spironolactone for these conditions based on the available research.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 358 results

    Related Research

    3 / 3 results